Physician profile
Adam J Rana
NPI 1922273143
$329,714.80
in general payments reported to CMS, 2019-2025
11 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $13K · 2021: $33K · 2022: $129K · 2023: $73K · 2024: $42K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Travel and Lodging: $19K · Food and Beverage: $6,493 · Education: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,620.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,958.00 |
| Travel and Lodging | $19,377.62 |
| Food and Beverage | $6,493.43 |
| Education | $384.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $323,825.09 | 2019-2025 | Journey II, Real Intelligence, Polarstem |
| Zimmer Biomet Holdings, INC. | $2,335.96 | 2019-2025 | Persona, G7, Avenir |
| Heron Therapeutics, INC. | $2,053.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $494.35 | 2020-2024 | Iovera, Exparel, Zilretta |
| Kairos Surgical INC | $437.68 | 2025 | |
| Stryker Corporation | $155.72 | 2023-2025 | Mako, Triathlon, Insignia |
| Abbvie INC. | $114.35 | 2022 | |
| Restor3d, INC. | $102.05 | 2023 | |
| Medtronic USA, INC. | $89.00 | 2020 | |
| Organogenesis INC. | $83.60 | 2023 | Puraply |
| Arthrex, INC. | $24.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Rana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.